During the last session, ContraFect Corporation (NASDAQ:CFRX)’s traded shares were 2,127,325, with the beta value of the company hitting 0.96. At the end of the trading day, the stock’s price was $4.2, reflecting an intraday loss of -8.1% or -$0.37. The 52-week high for the CFRX share is $8.455, that puts it down -101.31% from that peak though still a striking +1.9% gain since the share price plummeted to a 52-week low of $4.12. The company’s market capitalization is $165.2 Million, and the average intraday trading volume over the past 10 days was 1.5 Million shares, and the average trade volume was 966.53 Million shares over the past three months.
ContraFect Corporation (CFRX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2. CFRX has a Sell rating from none of the analyst(s) out of 5 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 4 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.2.
ContraFect Corporation (NASDAQ:CFRX): Trading Information
ContraFect Corporation (CFRX) registered a -8.1% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 15.68% in intraday trading to $4.98- this Monday, Apr 05, hitting a weekly high. The stock’s 5-day price performance is -6.25%, and it has moved by -13.22% in 30 days. Despite these dips, the overall price performance for the year is -16.83%. The short interest in ContraFect Corporation (NASDAQ:CFRX) is 3.32 Million shares and it means that shorts have 0 day(s) to cover.
The consensus price target of analysts on Wall Street is $14.2, which implies an increase of 238.1% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.5 and $22 respectively. As a result, CFRX is trading at a discount of 423.81% off the target high and 54.76% off the low.
ContraFect Corporation (CFRX) projections and forecasts
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 47.5%. While earnings are projected to return 68.8% in 2021, the next five years will return 12.7% per annum.
ContraFect Corporation (NASDAQ:CFRX)’s Biggest Investors
ContraFect Corporation insiders own 7.91% of total outstanding shares while institutional holders control 46.39%, with the float percentage being 50.37%. Federated Hermes, Inc. is the largest shareholder of the company, while 85 institutions own stock in it. As of Dec 30, 2020, the company held over 5.3 Million shares (or 13.47% of all shares), a total value of $26.75 Million in shares.
The next largest institutional holding, with 1.6 Million shares, is of BVF Inc.’s that is approximately 4.07% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $8.08 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Also, the Mutual Funds coming in first place with the largest holdings of ContraFect Corporation (CFRX) shares are Federated Hermes Kaufmann Small Cap Fund and Vanguard Total Stock Market Index Fund. Data provided on Jan 30, 2021 indicates that Federated Hermes Kaufmann Small Cap Fund owns about 5,297,188 shares. This amounts to just over 13.47 percent of the company’s overall shares, with a $25.9 Million market value. The same data shows that the other fund manager holds slightly less at 811.99 Thousand, or about 2.06% of the stock, which is worth about $4.1 Million.